![[Pyr1]-Apelin-13](https://file.medchemexpress.com/product_pic/hy-p1033.gif "Click to View [Pyr1]-Apelin-13 Product Detail")
![[Glp1]-FGL peptide acetate](https://file.medchemexpress.com/product_pic/hy-p3532.gif "Click to View [Glp1]-FGL peptide acetate Product Detail")
![[Pyr1]-Apelin-13, Pro(13C5,15N) TFA](https://file.medchemexpress.com/product_pic/hy-p1033s1.gif "Click to View [Pyr1]-Apelin-13, Pro(13C5,15N) TFA Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
47 Results for "
PYR
" in MedChemExpress (MCE) Product Catalog:
Products (47)
47 Results for "PYR" in MCE Product Catalog:
26
26 Publications Verification
Target:
Research Areas:
PYR-41 is a selective and cell permeable inhibitor of ubiquitin-activating enzyme E1 with an IC50 of < 10 μM, with little activity at E2 and E3.
9
9 Cited Publications
Target:
Research Areas:
Pyr3 is a selective inhibitor of transient receptor potential canonical channel 3 (TRPC3), with an IC50 of 700 nM for TRPC3-mediated Ca 2+ influx.
7
5
Target:
Research Areas:
3
3 Cited Publications
Cat. No.: HY-19408
CAS No.: 1315323-00-2
Target:
Research Areas:
Pyr10 is a pyrazole derivative and a selective TRP cation 3 (TRPC3) inhibitor. Pyr10 inhibits Ca 2+ influx in carbachol-stimulated TRPC3-transfected HEK293 cells with an IC50 of 0.72 μM (IC50 of 13.08 μM for store operated Ca 2+ entry in BRL-2H3 cells). Pyr10 has the ability to distinguish between receptor-operated TRPC3 and native stromal interaction molecule 1 (STIM1)/Orai1 channels .
1
1 Cited Publications
Synonyms: N-[4-[3,5-Bis(trifluoromethyl)-1H-PYRazol-1-yl]phenyl]-3-fluoro-4-PYRidinecarboxamide
Target:
Research Areas:
Pyr6 is a selective store operated calcium entry (SOCE) inhibitor with an IC50 of 0.49 μM. Pyr6 displays 37-fold higher potency for RBL SOCE than for TRPC3 ROCE .
1
1 Cited Publications
Cat. No.: HY-P3532
Synonyms: [pGlu1]-FGL peptide acetate; [PYR1]-FGL peptide acetate
Target:
Research Areas:
Target:
Research Areas:
BMS-986224 is a potent, selective and orally active APJ receptor agonist (Kd = 0.3 nM). BMS-986224 exhibits similar receptor binding and signaling profile to (Pyr 1) apelin-13. BMS-986224 has the potential for the research of heart failure .
Cat. No.: HY-P10925A
Synonyms: (Z)-FOG-001; I-67
Target:
Research Areas:
PYR01 is a non-nucleoside reverse transcriptase inhibitor and a killing activator targeting HIV infected cells. PYR01 has cytokilling and antiviral properties of HIV-1 infection with the IC50 values of 27.5nM and 39.7nM, respectively. PYR01 leads to selective cytotoxicity by promoting HIV-1 Gag-Pol dimerization and HIV-1 protease intracellular activation. PYR01 can be used in the study of HIV .
Cat. No.: HY-W010929
CAS No.: 223437-11-4
Cat. No.: HY-P4463
CAS No.: 38280-53-4
Target:
Research Areas:
Cat. No.: HY-P4882A
Target:
Research Areas:
Cat. No.: HY-P4349A
CAS No.: 1255501-99-5
Target:
Research Areas:
Cat. No.: HY-W011750
CAS No.: 32159-21-0
Synonyms: Cbz-L-PYRoglutamic acid
Target:
Research Areas:
Cat. No.: HY-122142A
CAS No.: 127428-47-1
Synonyms: S-2366 (hydrochloride)
Target:
Research Areas:
Pyr-Pro-Arg-pNA (S-2366) hydrochloride is a chromogenic peptidyl substrate, and a noncompetitive inhibitor that occupies the active sites of FXIa and FXIa-LC to block factor IX activation. Pyr-Pro-Arg-pNA hydrochloride functions as a hydrolyzable substrate for FXIa’s catalytic domain, human APC, murine APC, and purified plasma kallikrein .
Cat. No.: HY-P2000
CAS No.: 79775-19-2
Synonyms: (PYR6,Pro9)-Substance P
Target:
Research Areas:
Cat. No.: HY-169358
CAS No.: 3120166-93-7
Target:
Research Areas:
L134 is a BRD4 PROTAC degrader with a DC50 of 7.36 nM. L134 induces BRD4 protein degradation without inhibiting BRD4 gene expression, and recruits the E3 ubiquitin ligase DCAF11 to mediate this process, which can be blocked by proteasome inhibitors (MG132 (HY-13259), PS341 (HY-10227)) and E1 ubiquitin ligase inhibitors (PYR41 (HY-13296), MLN4924 (HY-70062)). L134 inhibits cancer cell migration, promotes cancer cell apoptosis and exerts antiproliferative activity. L134 can be used in studies related to triple-negative breast cancer .
Cat. No.: HY-P1033S1
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
